News | Neuro Imaging | July 29, 2016

Can a Brain Scan Early in Stress Predict Eventual Memory Loss?

neuo imaging, MRI

Brain scans early in stress show hippocampal volume shrinkage, a physical change in the brain which can predict eventual memory loss. Image courtesy of NCBS.

Work pressures, money issues, exams, perhaps an illness in the family — these are common strains in every person's life. But when such daily battles are fought over long periods of time, we become subject to chronic stress.

This chronic stress could be affecting a part of our brain known as the hippocampus — the seat of factual and declarative memory. The hippocampus is a pair of curved structures at the base of our brains and encodes memories of facts and events, such as names, phone numbers, dates and daily events that we need to run our lives.

New research now shows that even a brief period of stress can cause the hippocampus to start shrinking. This shrinking of the hippocampus — a change in the brain's structure — actually precedes the onset of a change in behavior, namely, the loss of memory. "Until now, no one actually knew the evolution of these changes. Does the hippocampus shrink before or after memory loss? Or do the two happen hand-in-hand?" asked Sumantra Chattarji, one of the main investigators in this study.

To address this, a collaborative project involving Chattarji's group from the National Centre for Biological Sciences (NCBS), Bangalore and Shane O'Mara's lab at Trinity College, Dublin, was begun using rats as a model system.

Rats react to stress much as humans do — they develop anxiety-related behaviors and their ability to form memories are affected. Long years of research have established well-studied ways to test rats' memories and responses to various forms of stress. This makes rats widely used models to study brain- and behavior-related questions.

In the current study, rats were subjected to stress for two hours every day over 10 days. The rats' brains were examined with MRI scans on several days over the course of the study, and their ability to form memories were assessed repeatedly using two different tests.

Striking results emerged in the first set of MRI scans taken after just three days of stress — the hippocampus of every stressed rat had shrunk. "It was a totally unexpected result. Normally structural changes are seen in the brain after a long time — say 10 to 20 days. Three days doesn't even count as chronic stress," said Chattarji.

Five days after stress exposure, the rats' hippocampus-based ability to make memories were tested. Here again, the researchers were in for a surprise. Stressed rats performed almost as well as unstressed rats.

"Volume loss and shrinkage has already happened, yet spatial memory is still holding up," said Chattarji.

At the end of the chronic stress regimen, the hippocampus of stressed rats had shrunk even more. Further, a second and different memory test performed after this scan, showed stark differences between stressed and unstressed rats. Stressed rats performed poorly in this test compared to unstressed rats.

These findings, published in the journal Scientific Reports, also detail other interesting aspects of how the brain changes in structure during stress. In the early days of stress, shrinkage in the left hippocampus is more pronounced, but at the end of ten days, the right hippocampus loses the most volume.

"Right now, we don't really know the functional significance of this. There is some evidence that in mice undergoing social stress, only the left hippocampus shrinks. If there is any inherent difference between the left and right hippocampus, that needs to be studied," said Mostafizur, a Ph.D. student with Chattarji and the lead author of the study.

Another discovery is that there are individual differences amongst the rats in how much the chronic stress regime affected them. The amount of shrinkage in a rat's hippocampus on day 3 can predict the shrinkage seen at the end of the 10-day stress period. The higher the shrinkage, the worse the rats' performance in memory tests at the end of the stress.

"This makes it even stronger that volume loss is a pretty good predictor of what the behavioral consequences will be at a much later stage," said Chattarji.

Many different groups, including Chattarji's have studied stress in rodent models for a long time. "What comes out in our study is that there are individual differences between rats," said Mostafizur. "In today's world, with so much talk about personalised medicine, these results could have huge implications for future studies on human disease." 

Related Content

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017.

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017, and who had health records for at least one year prior to the mammogram. The algorithm was trained on 9,611 mammograms. Image courtesy of Radiology.

Feature | Artificial Intelligence | July 19, 2019 | Michal Chorev
Breast cancer is the global leading cause of cancer-related deaths in women, and the most commonly diagnosed cancer...
Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Feature | Contrast Media | July 18, 2019 | By Greg Freiherr
Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n
AAPM 2019 Features More Than 40 Presentations on ViewRay's MRIdian MRI-guided Radiotherapy
News | Image Guided Radiation Therapy (IGRT) | July 16, 2019
ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the...
FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance...
Insightec's Exablate Neuro Approved With GE Signa Premier MRI in U.S. and Europe
News | Focused Ultrasound Therapy | July 10, 2019
GE Healthcare and Insightec announced U.S. Food and Drug Administration (FDA) approval and CE mark for Insightec’s...
Delta T1 Maps Provide Quantitative, Automated Solution to Assess Brain Tumor Burden
News | Neuro Imaging | July 05, 2019
Imaging Biometrics LLC (IB) a subsidiary of IQ-AI Ltd., is highlighting a recently published study in the American...
Medic Vision Wins Japanese PMDA Clearance for iQMR Image Reconstruction Solution
News | Magnetic Resonance Imaging (MRI) | July 05, 2019
Medic Vision Imaging Solutions announced that its 3-D iterative image reconstruction technology for shortening magnetic...
Bay Labs Announces New Echocardiography Guidance Software Data at ASE 2019 Scientific Sessions
News | Cardiovascular Ultrasound | June 20, 2019
Bay Labs announced that new data on the company’s first-of-its-kind deep learning investigational guidance software...
Third FDA Clearance Announced for Zebra-Med's AI Solution for Brain Bleed Alerts
Technology | Artificial Intelligence | June 19, 2019
Zebra Medical Vision announced it has received its third U.S. Food and Drug Administration (FDA) 510(k) clearance for...